Success strategies for cell and gene therapy 3.0: 2021 Wrap-up and Tools of Tomorrow

White Paper

The industry is at a pivotal point in preparing for the scaling and industrialization required to treat larger patient populations and there is an opportunity to solve operational challenges facing “CGT 3.0” through a combination of innovation and proven success strategies.

Overview

This article explores both the ongoing and new challenges facing the industry and presents relevant solutions to the challenges for allogeneic and solid tumor therapies in the interest of supporting the development and widespread access and adoption of safe CGTs. Download now to learn more!